Sitemap > Breaking Research > Immunology & Inflammatory Diseases
Displaying 1051 - 1100 of 5698 results
- Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
- Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
- Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipients.
- Toll-like receptor 2 antagonists. Part 1: preliminary SAR investigation of novel synthetic phospholipids.
- Optimization of CCR4 antagonists: side-chain exploration.
- Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK.
- Negative regulation of Toll-like-receptor signaling by IRF-4.
- Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients.
- Roles of cyclooxygenase-2 and prostacyclin/IP receptors in mucosal defense against ischemia/reperfusion injury in mouse stomach.
- Effect of montelukast on exhaled leukotrienes and quality of life in asthmatic patients.
- Glycopyrrolate causes prolonged bronchoprotection and bronchodilatation in patients with asthma.
- Cutting edge: macrophage migration inhibitory factor is necessary for progression of experimental autoimmune encephalomyelitis.
- Inhibition of histone deacetylase suppresses osteoclastogenesis and bone destruction by inducing IFN-beta production.
- IL-4 inhibits the expression of mouse formyl peptide receptor 2, a receptor for amyloid beta1-42, in TNF-alpha-activated microglia.
- Effects of (R)- and (S)-isomers of beta-adrenergic agonists on eosinophil response to interleukin-5.
- Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis.
- Biological drug use: US perspectives on indications and monitoring.
- IKK{beta} as a target for treatment of inflammation induced bone loss.
- Cyclical upregulated iNOS and long-term downregulated nNOS are the bases for relapse and quiescent phases in a rat model of IBD.
- Effect of nociceptin in acid-evoked cough and airway sensory nerve activation in guinea pigs.
- Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosis.
- Identification of vascular progenitor cells in pulmonary arteries of patients with chronic obstructive pulmonary disease.
- Transforming growth factor-beta induces airway smooth muscle hypertrophy.
- Reduction of colitis by prebiotics in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation.
- Infliximab treatment does not induce organ-specific or nonorgan-specific autoantibodies other than antinuclear and anti-double-stranded DNA autoantibodies in Crohn's disease.
- Hemin-activated macrophages home to the pancreas and protect from acute pancreatitis via heme oxygenase-1 induction.
- Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides.
- BLyS and APRIL in rheumatoid arthritis.
- Curcumin therapy in inflammatory bowel disease: a pilot study.
- Anti-RANKL therapy for inflammatory bone disorders: Mechanisms and potential clinical applications.
- Regulation of lung injury and repair by Toll-like receptors and hyaluronan.
- Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases.
- Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite.
- Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus.
- A role for the phagosome in cytokine secretion.
- Targeting histone deacetylase 2 in chronic obstructive pulmonary disease treatment.
- The therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritis.
- Phosphodiesterase-4 as a potential drug target.
- CXCL12 overexpression and secretion by aging fibroblasts enhance human prostate epithelial proliferation in vitro.
- Generation of adenosine A3 receptor functionally humanized mice for the evaluation of the human antagonists.
- A protective role for proteinase activated receptor 2 in airways of lipopolysaccharide-treated rats.
- Inhibition of atherogenesis in LDLR knockout mice by systemic delivery of adeno-associated virus type 2-hIL-10.
- A new vector for controllable expression of an anti-HER2/neu mini-antibody-barnase fusion protein in HEK 293T cells.
- The effects of diacerhein on mechanical allodynia in inflammatory and neuropathic models of nociception in mice.
- Effect of thalidomide on cardiac remodeling in chronic heart failure: results of a double-blind, placebo-controlled study.
- Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance.
- Cutting edge: murine CD59a modulates antiviral CD4+ T cell activity in a complement-independent manner.
- Modulation of ovalbumin-induced airway inflammation and hyperreactivity by tolerogenic APC.
- Glucosamine abrogates the acute phase of experimental autoimmune encephalomyelitis by induction of Th2 response.
- Effects of aryl hydrocarbon receptor signaling on the modulation of TH1/TH2 balance.
< Previous 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | 100 | 101 | 102 | 103 | 104 | 105 | 106 | 107 | 108 | 109 | 110 | 111 | 112 | 113 | 114 Next >